Riskpilot← Back to searchSign inGet full accessFOTENS KLINIKK AS
ASActiveOrg 918588981Kjellengveien 2C, 3125 TønsbergOther human health activities n.e.c. · NACE 8699Est. 20171 employees
Revenue 2024
NOK 414K
+35% vs 2023
EBITDA margin
9.4%
+139% vs 2023
Equity ratio
-110.1%
Financial strength
Net profit 2024
NOK 30K
+136% vs 2023
| Revenue | NOK 414K | +35% |
| EBITDA | NOK 39K | +139% |
| Net profit | NOK 30K | +136% |
| Total assets | NOK 97K | +34% |
| Equity | NOK -106K | +22% |
| Employees | 1 | — |
Legal name
FOTENS KLINIKK AS
Org number
918588981
Legal form
Aksjeselskap
NACE code
8699 · Other human health activities n.e.c.
Founded
20. februar 2017
Share capital
NOK 30 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder og nestleder hver for seg.
Company purpose
Fotterapi, behandling av fotproblemer, kjøp og salg av forskjellige produkter i naturlig tilknytning til dette, samt bedrive informasjon/foredragsvirksomhet innenfor området.
Address
Kjellengveien 2C, 3125 Tønsberg
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 132 | 254 | 271 | 306 | 414 |
| Staff expenses | −32 | −98 | −118 | −128 | −187 |
| EBITDA | −0 | 21 | 5 | 16 | 39 |
| Depreciation & amort. | −5 | −4 | −4 | −4 | −0 |
| EBIT | −6 | 16 | 1 | 12 | 39 |
| Net financials | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | −6 | 16 | 1 | 12 | 39 |
| Tax | −0 | −0 | 5 | −1 | 9 |
| Net profit | −6 | 16 | −4 | 13 | 30 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 53 | 75 | 62 | 72 | 97 |
| Equity | −162 | −146 | −150 | −137 | −106 |
| Long-term debt | 138 | 138 | 141 | 138 | 116 |
| Short-term debt | 77 | 83 | 71 | 71 | 87 |
| Total debt | 215 | 221 | 212 | 209 | 203 |
EBITDA margin
9.4%
This company
15.8%
Market median
-41% vs market
20202024
Equity ratio
-110.1%
This company
38.2%
Market median
-388% vs market
20202024
Return on equity
3047000.0%
This company
18.4%
Market median
+16559683% vs market
20202024
Net profit margin
7.4%
This company
8.1%
Market median
-9% vs market
20202024
Asset turnover
4.29×
This company
1.12×
Market median
+283% vs market
20202024
Debt / equity
1.91×
This company
0.62×
Market median
-208% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
HR Chief Executive Officer | Chief Executive Officer | 2017 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2017 | |
| Deputy Chairman | 2017 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of FOTENS KLINIKK AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Hege Rogne | Chief Executive Officer | 0 companies |
| Monica Rogne | Board of Directors | 0 companies |
| Jan Kjetil Wik | Deputy Chairman | 0 companies |